cagrisema vs semaglutide is one of the most #potent #weightloss medication developed till date! Cagrisema on an average causes 9% additional weight loss over # 2.4mg/week! Cagrisema is a fixed-dose combination of semaglutide 2.4mg + # Loss of firmness glp-1 liver toxicity Multiple Package Size:6-month supply

cagrisema vs semaglutide is one of the most #potent #weightloss medication developed till date! Cagrisema on an average causes 9% additional weight loss over # 2.4mg/week! Cagrisema is a fixed-dose combination of semaglutide 2.4mg + # Loss of firmness glp-1 liver toxicity Multiple Package Size:6-month supply

glp-1 liver toxicity Multiple target tissue effects of analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Glucagon-like peptide-1 and glucagon-like peptide-2 –

And 36.1 per cent of the semaglutide group lost more than 20 per cent of their body weight – something nobody at all in the placebo group achieved

Loss of firmness

Package Size:6-month supply

The FDA is reviewing the drug for the condition